TREATMENT READING

Myelodysplastic Syndromes

Choose a source section by treatment, subtype or setting. Patient and professional reading are labelled separately.

Selected text from the National Cancer Institute, with original links and dates. This Triangle reading page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.

2 studies cited in this topic · see design and results →

Find a treatment or settingReading level

Explore 4 related disease and treatment settings → · Source-derived catalogue; clinical review pending.

17 sections · Source headings, not a ranked treatment list

For patients · General Information About Myelodysplastic Syndromes

Age and past treatment with chemotherapy or radiation therapy affect the risk of a myelodysplastic syndrome.

For patients · General Information About Myelodysplastic Syndromes

Certain factors affect prognosis (chance of recovery) and treatment options.

For patients

Treatment Option Overview

For patients · Treatment Option Overview

Key Points

For patients · Treatment Option Overview

There are different types of treatment for patients with myelodysplastic syndromes.

For patients · Treatment Option Overview

Treatment for myelodysplastic syndromes includes supportive care, drug therapy, and stem cell transplant.

For patients · Treatment Option Overview

The following types of treatment are used:

For patients · Treatment Option Overview / The following types of treatment are used:

Supportive care

For patients · Treatment Option Overview / The following types of treatment are used:

Drug therapy

For patients · Treatment Option Overview / The following types of treatment are used:

Chemotherapy with stem cell transplant

For patients · Treatment Option Overview

New types of treatment are being tested in clinical trials.

For patients · Treatment Option Overview

Treatment for myelodysplastic syndromes may cause side effects.

For patients · Treatment Option Overview

Patients may want to think about taking part in a clinical trial.

For patients · Treatment Option Overview

Patients can enter clinical trials before, during, or after starting their treatment.

For patients · Treatment Option Overview

Follow-up tests may be needed.

For patients

Treatment of Myelodysplastic Syndromes

For patients

Treatment of Relapsed or Refractory Myelodysplastic Syndromes

Preserved source evidence · Independent clinical review pending · Not medical advice